Study: Oxford Covid-19 vaccine triggers immune response

Researchers from Oxford have published new results from their ongoing trails of a possible Covid-19 vaccine. During the last trial that involved 1,077 people, it showed that the experimental vaccine not only leads the patients to develop antibodies but also T-cells that are able to fight the virus.

The United Kingdom has already ordered 100 million doses of the vaccine. Further trials are still underway to determine if patients develop a long term immunitiy.